francine: on this episode of leaders with laqua, i traveled to the headquarters in copenhagen, denmark. i asked him about the global sensation, how he's navigating the companies rise, and the sweeping changes they could bring across a range of industries. thank you so much for being on bloomberg with us. after decades of research, basically you find a molecule that changes everything in terms of weight loss drugs. were you taken by surprise at the appetite for these drugs and how mainstream they are? lars: i would say there are many surprises when you get a product like that. it starts with surprises in the innovation because there are many shots being made and most fail. the winners are the ones that surprise people the most. francine: why do you think this surprise or success wasn't expected, did it capture something in society that you are not ready for? >> i think we have seen many decades of our company focused on type one diabetes and because of lifestyle changes in genetics, there was this, but for many years type 2 diabetes was not intensively treated and then there was -- that